Dermatologist's Take
Dupilumab is an injectable biologic for moderate to severe eczema that creams cannot control. It targets the IL-4 and IL-13 immune signals, works without routine blood tests, and is generally well tolerated, though eye irritation is a common side effect. It controls the disease with ongoing every-2-week shots but does not cure it.
At a glance
- AKA: Dupixent (brand name)
- Drug Class: Biologic; monoclonal antibody that blocks IL-4 and IL-13 signaling
- Rx or OTC: Prescription only (Rx)
- Typical Strength/Dose: For most adults, a starting dose of 600 mg (two shots), then 300 mg every 2 weeks
- Time to Work: Itch can improve within a few weeks; skin clearing builds over 3 to 4 months
- Evidence Level: Strong. Large trials support its use for moderate to severe eczema.
- Important: No routine blood tests are needed. The most notable side effect is eye irritation (conjunctivitis).
What is it?
What is it text.
How it works
Eczema is partly driven by two immune signals called interleukin-4 (IL-4) and interleukin-13 (IL-13). These signals push the immune system toward the overactive, itchy, inflamed state seen in eczema. Dupilumab is a lab-made antibody that blocks the shared receptor these two signals use. By turning down IL-4 and IL-13, it calms the inflammation at its source. It targets specific signals rather than broadly weakening the whole immune system, so it is not a traditional immunosuppressant.
What it treats
How it's typically used
Dupilumab is given as an injection under the skin (subcutaneous), usually in the thigh, belly, or upper arm. It comes in a prefilled syringe or a prefilled pen.
For most adults, treatment starts with a loading dose of 600 mg, given as two 300 mg shots in different spots. After that, the usual dose is 300 mg every 2 weeks. Doses for children and teens are lower and are based on age and weight. After training, many people give the shots to themselves at home. It is meant for long-term, ongoing use to keep eczema controlled. Unlike some other systemic eczema drugs, it does not require routine blood test monitoring.
Common side effects
- Injection site reactions, such as redness, swelling, or soreness
- Eye and eyelid problems, most often conjunctivitis (pink, itchy, irritated eyes)
- Dry eyes
- Cold sores or other herpes infections
- Temporary rise in a blood cell called eosinophils
- Joint aches (uncommon)
Serious side effects
Call your doctor if you notice:
- Signs of an allergic reaction — trouble breathing, swelling of the face, lips, mouth, or throat, hives, fainting, or dizziness. Seek emergency care for these.
- Eye problems that worsen — eye pain, changes in vision, or eye redness that does not clear up
- New or worsening joint pain
- Signs of a serious infection
Severe allergic reactions are rare but need immediate care.
Who shouldn't take it
- People with a known allergy to dupilumab or any of its ingredients
- Use caution if you have an active parasitic (helminth) infection, which should be treated first
- Talk to your doctor before any vaccinations, since live vaccines are generally avoided during treatment
- People with existing eye conditions should tell their doctor, as eye side effects can occur